Home > Financial Ratios > AURO LABORATORIES

AURO LABORATORIES
Core EBITDA Growth

    Back to All Ratios
AURO LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

AURO LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -66.65128.22-6.71-52.3565.67

What is the latest Core EBITDA Growth ratio of AURO LABORATORIES ?

The latest Core EBITDA Growth ratio of AURO LABORATORIES is -66.65 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-66.65
Mar2024128.22
Mar2023-6.71
Mar2022-52.35
Mar202165.67

How is Core EBITDA Growth of AURO LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -66.65
Negative
Mar2024 128.22
Positive
Mar2023 -6.71
Negative
Mar2022 -52.35
Negative
Mar2021 65.67 -

Other Financial Ratios of AURO LABORATORIES


Compare Core EBITDA Growth ratio of peers of AURO LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AURO LABORATORIES ₹164.2 Cr -5.6% -9.2% 15.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


AURO LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AURO LABORATORIES

-5.6%

-9.2%

15.4%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses